Compare MXCT & DPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MXCT | DPRO |
|---|---|---|
| Founded | 1999 | 1998 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.0M | 169.4M |
| IPO Year | 2021 | N/A |
| Metric | MXCT | DPRO |
|---|---|---|
| Price | $1.61 | $7.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $7.50 | ★ $15.67 |
| AVG Volume (30 Days) | 1.4M | ★ 1.4M |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $34,419,000.00 | $5,335,758.00 |
| Revenue This Year | N/A | $56.53 |
| Revenue Next Year | $10.69 | $137.77 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 26.74 |
| 52 Week Low | $1.26 | $1.63 |
| 52 Week High | $5.20 | $14.40 |
| Indicator | MXCT | DPRO |
|---|---|---|
| Relative Strength Index (RSI) | 53.02 | 49.17 |
| Support Level | $1.48 | $6.07 |
| Resistance Level | $1.65 | $8.36 |
| Average True Range (ATR) | 0.08 | 0.68 |
| MACD | 0.01 | 0.14 |
| Stochastic Oscillator | 78.38 | 53.44 |
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.